Vaxigrip suspension for injection in prefilled syringe.Influenza vaccine (split virion, inactivated) Malta - English - Medicines Authority

vaxigrip suspension for injection in prefilled syringe.influenza vaccine (split virion, inactivated)

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection - influenza vaccine (split virion, inactivated) 15 µg - vaccines

Vaxigrip Tetra Suspension for injection / Quadrivalent influenza vaccine (split virion, inactivated) Malta - English - Medicines Authority

vaxigrip tetra suspension for injection / quadrivalent influenza vaccine (split virion, inactivated)

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection in pre-filled syringe - influenza vaccine (split virion, inactivated) a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022 ivr-238 15 µg a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227 15 µg b/austria/1359417/2021 - like strain (b/austria/1359417/2021 bvr-26 15 µg b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) - vaccines

Influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes

split virion, inactivated - influenza virus split virion - suspension for injection

PANVAX H1N1 VACCINE JUNIOR H1N1 pandemic influenza vaccine (split-virion, inactivated) 0.25mL suspension for injection pre-fille Australia - English - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine junior h1n1 pandemic influenza vaccine (split-virion, inactivated) 0.25ml suspension for injection pre-fille

seqirus pty ltd - influenza virus haemagglutinin, quantity: 7.5 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 5mL multi-dose injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 5ml multi-dose injection vial

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate; thiomersal - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 0.5mL injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 0.5ml injection pre-filled syringe

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 10ml multi-dose injection vial

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate; thiomersal - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

Quadrivalent influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

quadrivalent influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes

split virion, inactivated) suspension for injection 0.5ml pre-filled syringes (sanofi - influenza virus split virion - suspension for injection

Influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes

split virion, inactivated - influenza virus split virion - suspension for injection

Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) European Union - English - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,